PTC Therapeutics, Inc.

PTCTNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
78.59 USD
↗ 0.07 (0.09%)AT CLOSE (11:59 AM EDT)
78.56
↘ 0.03 (0.04%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
78.56
↘ 0.03 (0.04%)
🟢Market: OPEN

Shares of PTC Therapeutics, Inc. (PTCT) are trading at $78.82. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (103.5%) and a bullish Golden Cross on the moving averages. Furthermore, PTCT is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jul 17, 2026.

Open?$77.52
High?$79.41
Low?$77.47
Prev. Close?$78.52
Volume?704.1K
Avg. Volume?2.3M
VWAP?$78.57
Rel. Volume?0.30x
Bid / Ask
Bid?$58.64 × 100
Ask?$90.43 × 100
Spread?$31.79
Midpoint?$74.54
Valuation & Ratios
Market Cap?6.5B
Shares Out?82.9M
Float?78.8M
Float %?95.0%
P/E Ratio?N/A
P/B Ratio?-36.09
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsBiotech - Drug Development›Neuroscience & CNS
Employees
991
Market Cap
6.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ptcbio.com
Listed
2013-06-20
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
6
Momentum?
35
Short Sent.?
21
Piotroski F-Score?2/9Weak
Altman Z-Score?0.61Distress
Confidence?74%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.98%Squeeze Risk
Short Interest?17.3M
Days to Cover?5.4
Free Float78.8M
Avg Daily Volume3.2M
Settlement Date2026-06-30
Financial Health
Current Ratio?2.44Strong
Quick Ratio?2.36Strong
Cash Ratio?0.90Adequate
Debt/Equity?-1.62Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-36.09CHEAP▾
P/S?
Peers
100
S&P
14
7.87HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-309.4CHEAP▾
EV/Sales?
Peers
100
S&P
19
7.22HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
103.5%STRONG▾
ROA?
S&P
3
-6.5%WEAK▾
Cash Flow & Enterprise
FCF?$-226282000
Enterprise Value?$6.0B
Fundamentals ratios updated end of day
MarketsMoversWatchlist